Delivery Order W81K0225DA018-W81K0225FA138
Award Date 10/1/25
Potential Completion Date 9/30/26
Potential Value $62K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tacoma, WA 98431, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $1.997 million firm fixed price purchase order to Diasorin Inc. on October 1, 2024, for reagents and analyzers with an ultimate completion date of September 30, 2029. This award represents the exercise of Option One for Fiscal Year 2026 and does not utilize any set-aside designation. Diasorin Inc., a foreign-owned subsidiary of Italian-based Diasorin S.P.A., will perform work at its Stillwater, Minnesota facility. The company specializes in providing...
- The Defense Health Agency has awarded a $466,505.19 firm fixed-price purchase order to Diasorin Inc. for the procurement of immunoassay analyzers and reagents, with a performance period extending through September 30, 2028. The contract, awarded on October 1, 2025, will be performed at Diasorin's facility in Stillwater, Minnesota. No set-aside designation was utilized for this award. Diasorin Inc., a foreign-owned subsidiary of Italian-based Diasorin S.P.A., is a specialized medical...
- This federal contract was awarded to Diasorin Inc., a foreign-owned for-profit medical diagnostics company, by the Defense Health Agency. The $350,000 firm-fixed-price contract provides the agency with a range of diagnostic testing products and services, including analyzers, reagents, test kits, controls, and technical support. The contract was not set aside for a specific business category. Diasorin has a history of supporting federal healthcare programs through prime and subcontractor roles....
- This federal contract award for $350,000 was issued by the Defense Health Agency (DHA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The contract is for the provision of reagents and closely associated functions, with an ultimate completion date of September 30, 2017. This award is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. Diasorin Inc. is a subsidiary of the Italian-based Diasorin S.P.A. and has a significant presence in the U.S....
- This federal contract award to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company, is for the provision of reagents, equipment, and related services under a Blanket Purchase Agreement (BPA) call. The $100,000 fixed-price contract was issued by the Defense Health Agency (DHA), a component of the Department of Defense (DoD), to support medical operations across DoD and Department of Veterans Affairs (VA) healthcare facilities. Diasorin has a strong track record as a federal...
- The Defense Health Agency awarded a $929,972 firm fixed price purchase order to Diasorin Inc. on October 1, 2020, for immunochemistry reagents and supplies to support operations at Fort Moore, Georgia through October 31, 2025. This sole source contract, justified under Federal Acquisition Regulation 6.302-1 due to the proprietary nature of Diasorin's analyzers and reagents, provides consumables and supplies for chemiluminescence immunoassay analyzers currently installed at the Martin Army...
- This federal contract award, valued at $172,834.00, was issued by the Defense Health Agency to Diasorin Inc., a foreign-owned, for-profit company that specializes in diagnostic testing equipment, assays, reagents, and related services for the medical industry. The contract is a firm fixed-price Blanket Purchase Agreement (BPA) call to provide reagents, equipment, and peripherals. There was no set-aside used for this acquisition. Diasorin Inc. has a proven track record as a federal contractor,...
- This contract award, valued at $85,364.46, was issued by the Defense Health Agency (DHA) to the foreign-owned, for-profit company Diasorin Inc. The contract is for the provision of reagents under a delivery order, with a period of performance through September 30, 2025. This award is not associated with any set-aside designation. Diasorin Inc. is a subsidiary of the Italy-based medical diagnostics firm Diasorin S.P.A. The company has a strong track record as a federal contractor, providing...
- This is a $90,680.10 firm-fixed-price purchase order awarded by the Defense Health Agency to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The award is for DIASORIN LIAISON XL ANALYZERS and associated services, with a period of performance through August 31, 2025. Diasorin Inc. is a subsidiary of the Italian-based Diasorin S.P.A. and specializes in providing advanced diagnostic testing equipment, chemiluminescence immunoassay analyzers, reagents, assays, and related...
- The Defense Health Agency awarded a $4.61 million firm fixed price purchase order to Diasorin Inc. on October 1, 2025, for a cost-per-kit agreement to supply chemiluminescence immunoassay (CLIA) reagents, consumables, controls, and related products for testing at Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas. The contract, which runs through September 30, 2030, represents a sole source procurement targeting Diasorin as the exclusive supplier of LIAISON MeMed BV assays compatible...